Policy paper

New psychoactive substances: G8 statement on collection and sharing of data

Statement outlines the approaches to tackling challenges posed by NPS, covering the detection, analysis, identification, monitoring and reporting of synthetic drugs.

This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government


G8 statement of intent: collection and sharing of data on NPS

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.


New psychoactive substances (NPS) have changed the nature of the global drugs market. Substances that are not under international control, but mimic the effects of controlled substances, are now widely available.

G8 member states, the UN and the EU are committed to work together in developing a better understanding of NPS, and are committed to reducing the production, manufacture, distribution and demand for NPS.

Published 25 June 2013